Human β 2-adrenergic receptor gene haplotypes and venodilation in vivo

Clinical Pharmacology and Therapeutics

Volumn 78, Issue 3, 2005, Pages 232-238

  Bruck, Heike ^a   Leineweber, Kirsten ^a   Park, Jinny ^a   Weber, Melanie ^a   Heusch, Gerd ^a   Philipp, Thomas ^a   Brodde, Otto Erich ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; PHENYLEPHRINE; TERBUTALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG SENSITIVITY; FEMALE; GENETIC POLYMORPHISM; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IN VIVO STUDY; LONG TERM CARE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VEIN DILATATION; VENOCONSTRICTION; WILD TYPE; BLOOD FLOW; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HAND; HEART RATE; HETEROZYGOTE; INTRAVENOUS DRUG ADMINISTRATION; PHYSIOLOGY; VASCULARIZATION; VASODILATATION; VEIN;

ADRENERGIC BETA-AGONISTS; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HAND; HAPLOTYPES; HEART RATE; HETEROZYGOTE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PHENYLEPHRINE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; REGIONAL BLOOD FLOW; TERBUTALINE; VASOCONSTRICTOR AGENTS; VASODILATION; VEINS;

EID: 24344482075     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2005.06.002     Document Type: Article

References (23)

1. S. Guimaraes, D. Moura Vascular adrenoceptors an update Pharmacol Rev 53 2001 319 356
2. O.-E. Brodde, M.C. Michel Adrenergic and muscarinic receptors in the human heart Pharmacol Rev 51 1999 651 690
3. K.M. Small, D.W. McGraw, S.B. Liggett Pharmacology and physiology of human adrenergic receptor polymorphisms Annu Rev Pharmacol Toxicol 43 2003 381 411
4. S.L. Kirstein, P.A. Insel Autonomic nervous system pharmacogenomics a progress report Pharmacol Rev 56 2004 31 52
5. K. Leineweber, R. Büscher, H. Bruck, O.-E. Brodde β-Adrenoceptor polymorphisms Naunyn Schmiedebergs Arch Pharmacol 369 2004 1 22
6. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties Biochemistry 33 1994 9414 9419
7. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor J Biol Chem 268 1993 23116 23121
8. 2-adrenoceptors Circulation 103 2001 1048 1050
9. 2-adrenoceptor exhibits blunted desensitization of cardiac functional responses in vivo Am J Physiol Heart Circ Physiol 285 2003 H2034 H2038
10. 2-Adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo Pharmacogenetics 14 2004 517 522
11. 2-Adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population Clin Exp Allergy 28 1998 442 448
12. 2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo Pharmacogenetics 13 2003 59 66
13. 2-adrenergic receptor down-regulation Clin Pharmacol Ther 74 2003 255 263
14. W.H. Aellig A new technique for recording compliance of human hand veins Br J Clin Pharmacol 11 1981 237 243
15. 2- adrenoceptor-mediated positive inotropic effects attenuation by ketotifen Cardiovasc Res 40 1998 211 222
16. 2-Adrenoceptor polymorphism determines vascular reactivity in humans Hypertension 36 2000 371 375
17. 2-adrenergic receptor on agonist-mediated vascular desensitization N Engl J Med 345 2001 1030 1035
18. 2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans J Physiol 546.2 2003 583 589
19. 2-adrenergic receptor diplotypes Clin Pharmacol Ther 76 2004 27 37
20. 2-adrenergic receptor on the response to regular use of albuterol in asthma Am J Respir Crit Care Med 162 2000 75 80
21. E. Israel, V.M. Chinchilli, J.G. Ford, H.A. Boushey, R. Cherniack, T.J. Craig National Heart, Lung, and Blood Institute's Asthma Clinical Research Network Use of regularly scheduled albuterol treatment in asthma genotype-stratified, randomised, placebo-controlled cross-over trial Lancet 364 2004 1505 1512
22. 2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol Br J Clin Pharmacol 57 2004 68 75
23. 2-adrenergic receptors relevance to asthma J Allergy Clin Immunol 105 2000 S487 S492